We Build Bridges in Rare Diseases

We are called Strongbridge for a reason. We're building a strong clinical and financial foundation to connect patients with new treatments for rare diseases.

Focus. Commitment. Passion. That’s Strongbridge.

Agile Clinical Development

Strongbridge is committed to bridging treatment gaps as rapidly as possible. We are building rare disease franchises that aim to utilize accelerated regulatory pathways when possible.

Strongbridge Leadership Team

The Strongbridge leadership team exemplifies the company’s approach—rare focus, rare commitment, and rare passion.

Our People Are Our Foundation

Strongbridge is looking for smart, driven people to join our growing and dynamic team. Learn more at the Strongbridge Careers page.
Strongbridge Financial Information

We are building a strong financial foundation to enable clinical innovation

For accessibility-related questions, comments, or concerns about this digital property, please email [email protected] and we will reply to your message.

© 2021 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MLR-0010 V20 10/2020

  • Ireland Address:
    Suite 206, Fitzwilliam Hall
    Fitzwilliam Place, Dublin 2, D02 T292
    Ireland
  • U.S. Address:
    900 Northbrook Drive, Suite 200
    Trevose, PA 19053
    United States

Phone: +1 610-254-9200
[email protected]

Privacy Statement
Compliance Program